Join
Live feed
·
INSIDERFilingvia Quantisnow
Recursion Pharmaceuticals Inc. logo

Director Gibson Christopher converted options into 40,000 shares, sold $164,800 worth of shares (40,000 units at $4.12), was granted 30,346 shares and covered exercise/tax liability with 10,364 shares, increasing direct ownership by 2% to 933,821 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RXRX· Recursion Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RXRX (Recursion Pharmaceuticals Inc.) and more on Quantisnow.

Director Gibson Christopher converted options into 40,000 shares, sold $164,800 worth of shares (40,000 units at $4.12), was granted 30,346 shares and covered exercise/tax liability with 10,364 shares, increasing direct ownership by 2% to 933,821 units (SEC Form 4) | Quantisnow